Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell 3000E Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -3.21% | -5.62% | +2.72% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.72% | 81.38M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.47% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell 3000E Value Index